Meet the board

Board of Directors

Paul Jensen

Paul Jensen

Independent Chair – Chair Audit, Risk & Technology Committee

Mr Paul Jensen joined the Bubs Board as Non-Executive Director and Independent Chair of the Audit and Risk Committee in April 2023 and brings perspectives drawn from his extensive professional career. Paul is based in Sydney, Australia.

Paul has more than 20 years’ Board experience as a professional director with both ASX listed, public and private corporations across consumer goods, equity capital markets, banking, government, philanthropy, and indigenous affairs.

He brings an international perspective gained from an executive career working in New Zealand, Australia, and the United Kingdom. In both his executive and non-executive career Paul has been focused on shareholder value creation. Paul is a critical thinker and highly proficient in financial disciplines to manage risk, drive growth and create sustainable value. He is deeply committed to ensuring strong governance, risk management and compliance principles are actively exhibited, and that a constructive culture is present.

He currently holds the position of Non-Executive Director and Treasurer for the Australia Made Campaign Limited, which on behalf of the Australian Government administers the highly recognised and trusted Australian Made and ReMade in Australia trademarks, he is a Director of Alterra Limited and GNS Wholesale Limited. Paul is a Fellow of The Australian Institute of Company Directors.

Steve Lin

Steve Lin

Non-executive director – Member Nomination & Remuneration Committee Member Audit, Risk & Technology Committee

Mr Steve Lin has been a Director on the Bubs board since 2019 and is based in the USA. Steve represents Bubs’ largest shareholder, C2 Capital’s holding of 8.54% and is deeply committed to contributing to Bubs’ shareholder value creation. C2 Capital’s major investors include Alibaba, owner of the Tmall platform in China and Hema Fresh Foods.

Steve currently serves on the Board of three North American consumer products companies, Stella & Chewy’s, a leading pet food company in the US, Petcurean a leading pet food company in Canada and China and KDC/ONE, one of the world’s largest OEM/ODM manufacturers in beauty, personal care and home care.

A highly experienced board director, Steve has been doing business in China for 30 years including serving on company and university boards. More broadly, Steve also has more than 25 years of investment, operations, and management experience in Asia and the US. For the last 7 years Steve has been Managing Partner for C2 Capital, a private equity firm focused on investing in leading consumer products to provide growth capital to scale in the China market.

Prior to joining C2 Capital, Steve worked for Morgan Stanley, Goldman Sachs, GMAC Commercial Holding Corp (subsequently, Capmark Financial Group) and Laureate Education in New York, Hong Kong and Tokyo. Steve co-founded a non-profit organisation, Hands On Tokyo, and previously served on the Board of Directors of Xi’an Jiaotong-Liverpool University and Hunan International Economics University.

Steve has a bachelor’s degree in economics from Harvard College.

Joe Coote

Joe Coote

CEO & Managing Director

Joe is a globally experienced executive with over 20 years of leadership across FMCG, dairy, and infant nutrition. He is recognised for his strategic vision, operational excellence, and ability to drive transformation and growth in complex markets. During 12 years at Fonterra, he held senior leadership roles spanning supply chain, operations, and commercial functions. In the USA, he led over US$2B in sales, launched the Zeal brand, and established a US$120M specialty nutrition joint venture also managing major partnerships with Abbott Nutrition, Mead Johnson, and Premier Protein. Most recently as CEO of Darigold, the USA’s fourth-largest dairy cooperative, Joe led a major transformation program, delivering growth and margin gains across the FIT brand and infant formula categories. He also worked closely with regulatory bodies, including the FDA.

Joe brings a global mindset, deep industry expertise, and a passion for leading purpose-driven, high-performance teams.

Shareholder Enquiries
Alex Abeyratne, Sodali & Co.
+61 (0) 438 380 057
investors@bubsaustralia.com

Computershare Investor Services Pty Limited
+61 (0)3 9415 4000​
or 1300 850 505 (within Australia)
https://www.computershare.com/au